Tspan9 overexpression has been found to suppress the secretion of MMP9 and urokinase plasminogen activator (uPA) by inactivating the ERK1/2 signaling pathway, ultimately inhibiting the metastasis and proliferation of gastric cancer cells (Li et al., 2016). Here, TSPAN9 is linked to gastric cancer.